Skip to main content
SpringerLink
Log in

Reply

  • Correspondence
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chandra J, Parakh N, Sidharth, et al. Efficacy and safety of thalidomide in patients with transfusion-dependent thalassemia. Indian Pediatr. 2021;58:611–16.

    Article  Google Scholar 

  2. Cappellini M, Viprakasit V, Taher A, et al. A phase 3 Trial of luspatercept in patients with transfusion-dependent â-thalassemia. N Engl J Med 2020;13:1219–31.

    Article  Google Scholar 

  3. Naithani R, Chandra J, Sharma S. Safety of oral iron chelator deferiprone in young thalassaemics. Eur J Haematol. 2005;74:217–20.

    Article  CAS  Google Scholar 

  4. Ren Q, Zhou Y-L, Wang L, et al. Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia. Ann Hematol. 2018;97:1933–39.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India

    Jagdish Chandra

Authors
  1. Jagdish Chandra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jagdish Chandra.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chandra, J. Reply. Indian Pediatr 58, 1100–1101 (2021). https://doi.org/10.1007/s13312-021-2386-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-021-2386-0

Search

Navigation